BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30391728)

  • 1. Cell metabolomics identify regulatory pathways and targets of magnoline against prostate cancer.
    Sun H; Zhang AH; Liu SB; Qiu S; Li XN; Zhang TL; Liu L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():143-151. PubMed ID: 30391728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the perturbed metabolic pathways associating with prostate cancer cells and anticancer affects of obacunone.
    Xie J; Zhang AH; Qiu S; Zhang TL; Li XN; Yan GL; Sun H; Liu L; Wang XJ
    J Proteomics; 2019 Aug; 206():103447. PubMed ID: 31326558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics approaches and applications in prostate cancer research.
    Zhang A; Yan G; Han Y; Wang X
    Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
    Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
    Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics.
    Zhang P; Zhu W; Wang D; Yan J; Wang Y; He L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glaucocalyxin A on human liver cancer cells as revealed by GC/MS- and LC/MS-based metabolic profiling.
    Liu Y; Lu S; Zhao L; Dong X; Zhu Z; Jin Y; Chen H; Lu F; Hong Z; Chai Y
    Anal Bioanal Chem; 2018 May; 410(14):3325-3335. PubMed ID: 29651531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
    Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
    PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Fatty Acid Synthase Inhibition-Triggered Metabolic Flexibility in Prostate Cancer Cells through Untargeted Metabolomics.
    Oh JE; Jung BH; Park J; Kang S; Lee H
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations.
    Jayaraman A; Kumar P; Marin S; de Atauri P; Mateo F; M Thomson T; J Centelles J; F Graham S; Cascante M
    PLoS One; 2018; 13(2):e0192175. PubMed ID: 29466368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic network analysis of estrogen-stimulated MCF-7 cells: a comparison of overrepresentation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis.
    Maertens A; Bouhifd M; Zhao L; Odwin-DaCosta S; Kleensang A; Yager JD; Hartung T
    Arch Toxicol; 2017 Jan; 91(1):217-230. PubMed ID: 27039105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
    Meller S; Meyer HA; Bethan B; Dietrich D; Maldonado SG; Lein M; Montani M; Reszka R; Schatz P; Peter E; Stephan C; Jung K; Kamlage B; Kristiansen G
    Oncotarget; 2016 Jan; 7(2):1421-38. PubMed ID: 26623558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput metabolomics approach reveals new mechanistic insights for drug response of phenotypes of geniposide towards alcohol-induced liver injury by using liquid chromatography coupled to high resolution mass spectrometry.
    Zhang T; Zhang A; Qiu S; Sun H; Han Y; Guan Y; Wang X
    Mol Biosyst; 2016 Dec; 13(1):73-82. PubMed ID: 27896352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation in metabolomics to improve personalized healthcare.
    Cacciatore S; Loda M
    Ann N Y Acad Sci; 2015 Jun; 1346(1):57-62. PubMed ID: 26014591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics.
    Li XN; Zhang A; Wang M; Sun H; Liu Z; Qiu S; Zhang T; Wang X
    Sci Rep; 2017 Apr; 7():46234. PubMed ID: 28383015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
    Ji H; Liu Y; He F; An R; Du Z
    J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
    Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
    Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.